Latest Earnings Results: Q3 '26
Estimated EPS
$1.18
Reported EPS
$11.47
Surprise
+868.75%
Estimated Rev
$68.53M
Reported Rev
$60.65M
Surprise
-11.5%
• Reported GAAP EPS of $11.47 up 1562.32% YoY • Reported revenue of $113.48M up 26.30% YoY • National Health Investors' 2026 full-year guidance is net income attributable to common stockholders of $687M, NAREIT and Normalized FFO of $4.68-$4.70 per diluted share, and FAD of $236.6M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.65 | -- | -- | N/A |
Q3 '26 | $1.18 | $11.47 | 868.75% | BEAT |
Q2 '26 | $0.84 | $1.15 | 36.36% | BEAT |
Q1 '26 | $0.85 | $0.82 | -3.98% | MISSED |
Q4 '25 | $0.79 | $0.80 | 1.20% | BEAT |